Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review
Document Type
Article
Publication Date
1-1-2018
Abstract
BODIPYs are photosensitizers activatable by light to generate highly reactive singlet oxygen (1O2) from molecular oxygen, leading to tissue damage in the photoirradiated region. Despite their extraordinary photophysical characteristics, they are not featured in clinical photodynamic therapy. This review discusses the recent advances in the design and/or modifications of BODIPYs since 2013, to improve their potential in photodynamic cancer therapy and related areas.
Keywords
Antineoplastic Agents, Boron Compounds, Humans, Neoplasms, Photochemotherapy, Photosensitizing Agents
Divisions
fac_med
Funders
Postgraduate Research Grant (PPP) – Research, project no. PG222-2016A
Publication Title
Photochemical & Photobiological Sciences
Volume
17
Issue
11
Publisher
Royal Society of Chemistry
COinS